China's unique position in discovery and preclinical research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

China's unique position in discovery and preclinical research

Published:2007-01 Issue:1-2 Volume:12 Page:4-7
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Boutellier Roman,Ullman Fredrik

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference7 articles.

1. The Chemical and Pharmaceutical Industry in China;Festel,2005

2. Is more really less in China's new drug approvals?;Chenoweth;Drug Discov. Today,2005

3. Managing Global Innovation;Boutellier,2000

4. Self-selection and the earnings of immigrants;Borjas;Am. Econ. Rev.,1987

5. Who is coming back? The educational profile of returning migrants in the 1990s;Barrett;Irish Banking Review,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Policy Planning to Support Technological Innovation in the Pharmaceutical Industry;Disruptive Technology;2020

2. Seizing Opportunities for Markets of Discovery: The Reconfigurations of Value Chains in Pharmaceutical Industry in the Global South;Science, Technology and Society;2018-04-27

3. A research and development decision model for pharmaceutical industry: case of China;R&D Management;2017-08-29

4. National Technology Planning: A Case Study on the Biopharmaceutical Industry in China;Hierarchical Decision Modeling;2016

5. Policy Planning to Support Technological Innovation in the Pharmaceutical Industry;Advances in Medical Technologies and Clinical Practice;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP